Compare VOR & LWLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VOR | LWLG |
|---|---|---|
| Founded | 2015 | 1991 |
| Country | United States | United States |
| Employees | N/A | 34 |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 995.4M |
| IPO Year | 2021 | 2011 |
| Metric | VOR | LWLG |
|---|---|---|
| Price | $20.82 | $6.51 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $45.33 | N/A |
| AVG Volume (30 Days) | 1.2M | ★ 3.0M |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.79 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $236,855.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 147.74 |
| 52 Week Low | $1.62 | $1.99 |
| 52 Week High | $49.95 | $18.71 |
| Indicator | VOR | LWLG |
|---|---|---|
| Relative Strength Index (RSI) | 61.60 | 42.70 |
| Support Level | $11.62 | $6.15 |
| Resistance Level | $22.22 | $7.39 |
| Average True Range (ATR) | 1.44 | 0.50 |
| MACD | 0.11 | 0.11 |
| Stochastic Oscillator | 82.31 | 48.07 |
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Lightwave Logic Inc is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (EO) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Its Perkinamine family of EO polymers is designed for integration into silicon photonics (SiPh) and other photonic integrated circuit (PIC) platforms, supporting high-speed optical modulation with lower drive voltage requirements compared with some conventional silicon-based and III-V compound semiconductor approaches. The company operates as a single reportable segment.